Israel - English - Ministry of Health

astrazeneca (israel) ltd - saxagliptin as hydrochloride - film coated tablets - saxagliptin as hydrochloride 5 mg - saxagliptin - saxagliptin - monotherapy: onglyza is indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus.onglyza should not be used in patients with esrdcombination therapy: add-on combination: onglyza is indicated in patients with type 2 diabetes mellitus to improve glycemic control in combination with metformin, a thiazolidinedione (tzd), or a sulfonylurea (su), when the single agent alone, with diet and exercise, does not provide adequate glycemic control.initial combination: onglyza is indicated for use as initial combination therapy with metformin, as an adjunct to diet and exercise, to improve glycemic control in patients with type 2 diabetes mellitus when dual saxagliptin and metformin therapy is appropriate.onglyza should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis. in combination with insulin (with or without metformin), when this regimen alone, with diet and exercise, does not provide adequate glycaemic control.

Israel - English - Ministry of Health

astrazeneca (israel) ltd - saxagliptin as hydrochloride - film coated tablets - saxagliptin as hydrochloride 2.5 mg - saxagliptin - saxagliptin - monotherapy: onglyza is indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus.onglyza should not be used in patients with esrdcombination therapy: add-on combination: onglyza is indicated in patients with type 2 diabetes mellitus to improve glycemic control in combination with metformin, a thiazolidinedione (tzd), or a sulfonylurea (su), when the single agent alone, with diet and exercise, does not provide adequate glycemic control.initial combination: onglyza is indicated for use as initial combination therapy with metformin, as an adjunct to diet and exercise, to improve glycemic control in patients with type 2 diabetes mellitus when dual saxagliptin and metformin therapy is appropriate.onglyza should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis. in combination with insulin (with or without metformin), when this regimen alone, with diet and exercise, does not provide adequate glycaemic control.

Israel - English - Ministry of Health

gsk consumer healthcare, israel ltd - terbinafine hydrochloride - solution - terbinafine hydrochloride 1 % - terbinafine - terbinafine - fungal infections of the skin caused by dermatophytes such as trichophyton (e.g. t. rubrum, t. mentagrophytes, t. verrucosum, t. violaceum) , microsporum canis and epidermaphyton floccosum.yeast infections of the skin, principally those caused by the genus candida (e.g. candida albicans). pityriasis (tinea) versicolor due to pityrosporum orbiculare (also known as malassezia furfur).

Israel - English - Ministry of Health

bayer israel ltd - clotrimazole - vaginal tablets - clotrimazole 200 mg - clotrimazole - clotrimazole - infections in external female genital organs and vagina caused by clotrimazole-sensitive microorganisms such as fungi (candida albicans) and trichomonas.during treatment of vaginitis caused by trichomonas, canesten v must be combined with an oral trichomonacide (e.g metronidazole).

Israel - English - Ministry of Health

bayer israel ltd - clotrimazole - vaginal tablets - clotrimazole 200 mg - clotrimazole - clotrimazole - infections in external female genital organs and vagina caused by clotrimazole-sensitive microorganisms such as fungi (candida albicans) and trichomonas.during treatment of vaginitis caused by trichomonas, canesten v must be combined with an oral trichomonacide (e.g metronidazole).

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - tolterodine l-tartrate - capsules slow release - tolterodine l-tartrate 4 mg - tolterodine - tolterodine - for the treatment of patients with an overactive bladder with symptoms of urinary frequency, urgency or urge incontinence.

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - tolterodine l-tartrate - capsules slow release - tolterodine l-tartrate 2 mg - tolterodine - tolterodine - for the treatment of patients with an overactive bladder with symptoms of urinary frequency, urgency or urge incontinence.

Israel - English - Ministry of Health

bayer israel ltd - vardenafil as hydrochloride trihydrate - film coated tablets - vardenafil as hydrochloride trihydrate 10 mg - vardenafil - vardenafil - treatment of erectile dysfunction, which is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance. in order for levitra to be effective, sexual stimulation is required. not indicated for use by women.

Israel - English - Ministry of Health

bayer israel ltd - vardenafil as hydrochloride trihydrate - film coated tablets - vardenafil as hydrochloride trihydrate 20 mg - vardenafil - vardenafil - treatment of erectile dysfunction, which is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance. in order for levitra to be effective, sexual stimulation is required. not indicated for use by women.

Israel - English - Ministry of Health

ferring pharmaceuticals ltd - degarelix as acetate - powder and solvent for solution for injection - degarelix as acetate 120 mg - degarelix - degarelix - for the treatment of adult male patients with advanced hormone-dependent prostate cancer.